Study Name: PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
28 locations found
- Pfizer Investigational Site
Location: Durham, North Carolina 27704
- Pfizer Investigational Site
Location: Omaha, Nebraska 68114
- Pfizer Investigational Site
Location: Tyler, Texas 75702
- Pfizer Investigational Site
Location: Fort Worth, Texas 76177
- Pfizer Investigational Site
Location: Aurora, Colorado 80012
- Pfizer Investigational Site
Location: Littleton, Colorado 80120
- Pfizer Investigational Site
Location: Lone Tree, Colorado 80124
- Pfizer Investigational Site
Location: Parker, Colorado 80138
- Pfizer Investigational Site
Location: Denver, Colorado 80218
- Pfizer Investigational Site
Location: Denver, Colorado 80220
- Pfizer Investigational Site
Location: Scottsdale, Arizona 85258
- Pfizer Investigational Site
Location: Tucson, Arizona 85704
- Pfizer Investigational Site
Location: Tucson, Arizona 85710
- Pfizer Investigational Site
Location: Boulder, Colorado 80303
- Pfizer Investigational Site
Location: Colorado Springs, Colorado 80907
- Pfizer Investigational Site
Location: Colorado Springs, Colorado 80909
- Pfizer Investigational Site
Location: Lakewood, Colorado 80228
- Pfizer Investigational Site
Location: Longmont, Colorado 80501
- Pfizer Investigational Site
Location: Pueblo, Colorado 81008
- Pfizer Investigational Site
Location: Thornton, Colorado 80260
- Pfizer Investigational Site
Location: Henderson, Nevada 89014
- Pfizer Investigational Site
Location: Henderson, Nevada 89074
- Pfizer Investigational Site
Location: Henderson, Nevada 89052
- Pfizer Investigational Site
Location: Las Vegas, Nevada 89128
- Pfizer Investigational Site
Location: Las Vegas, Nevada 89148
- Pfizer Investigational Site
Location: Las Vegas, Nevada 89169
- Pfizer Investigational Site
Location: Seattle, Washington 98109
- Pfizer Investigational Site
Location: Seattle, Washington 98195
|